Turning Frustration Into Innovation: How CRP‑A Emerged as a Global Research Essential

While developing another product, we needed a highly potent, non‑human and non‑animal derived platelet activator that could deliver exceptional consistency and high potency.

That requirement narrowed down our choices dramatically. The Collagen Related Peptides available on the market came with challenges we couldn’t overlook such as : inconsistent batch‑to‑batch performance, frequent vortexing after reconstitution and stability issues that disrupted experiments

For our own research, these limitations weren’t just inconvenient, they simply were impossible to overlook in the products we were developing. So we made a decision that would change far more than we expected: we developed our own Collagen Related Peptide.

What we didn’t realise at the time was that this internal solution would resonate with so many scientists worldwide who were facing similar challenges.

That solution became CRP‑A. CRP‑A is a next‑generation, GPVI‑specific Collagen Related Peptide designed for reliability, potency, and stability. What began as a fix for our own challenge quickly grew into a product now used by thousands of researchers across the globe. Its performance and consistency continue to earn outstanding feedback from platelet biology labs, assay developers, and research teams internationally.

If you’d like to evaluate CRP‑A in your own work, feel free to reach out at Sales@pplusmedical.com and to learn more about CRP-A, please visit: https://lnkd.in/ekuEXfFc